| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/17/2002 | CN1359285A Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/17/2002 | CN1359262A Therapeutic anti-fungal nail preparation |
| 07/17/2002 | CN1358543A Recombination plasmid and application in disease prevention and control |
| 07/17/2002 | CN1358539A Ointment for treating ulcer and hyperplastic skin and preparation process |
| 07/17/2002 | CN1358538A Face beautifying tea |
| 07/17/2002 | CN1358537A Medicine for treating skin disease and preparation process |
| 07/17/2002 | CN1358533A Ointment for treating burn and scale |
| 07/17/2002 | CN1358524A Spraying medicine for treating tinea pedis and process for making same |
| 07/17/2002 | CN1358523A Toxic substance removing ointment |
| 07/17/2002 | CN1358509A Pearl mulit-effect face cosmetic solution |
| 07/17/2002 | CN1358506A Pearl face-beautifying tea |
| 07/17/2002 | CN1358502A Traditional Chinese medicine for treating burn and scald and preparation process |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087626C Stain clearing and face beautifying pill |
| 07/17/2002 | CN1087621C Ointment for treating burn and scald |
| 07/17/2002 | CA2367825A1 Antithrombin iii for disorders caused by angiogenesis |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420542 Tie ligands |
| 07/16/2002 | US6420531 Polypeptides prepared by expressing in a host cell a dna code with amino acid sequence |
| 07/16/2002 | US6420431 Methods for treating disordered tissue through agitated delivery of anti-infective compositions |
| 07/16/2002 | US6420424 CCR-3 receptor antagonists |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 07/16/2002 | US6420394 Topically applied pharmaceutical formulation |
| 07/16/2002 | US6420392 Paf receptor antagonists and/or by inhibiting the enzyme 5-lipoxygenase. |
| 07/16/2002 | US6420385 Substituted pyrimidinone and pyridone compounds and methods of use |
| 07/16/2002 | US6420382 Tyrosine kinase inhibitors |
| 07/16/2002 | US6420376 Amido spiropiperidines promote the release of growth hormone |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420360 Sultam and sultone derived oxazolidinones |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420157 Expression vector coding enzymatic polypeptide for use in the treatment of inflammation and sexual disorders; for use in laundry detergents |
| 07/16/2002 | US6419962 Plant extract in carrier |
| 07/16/2002 | US6419950 Extracts of zanthoxylum bungeanum, and pharmaceutical and cosmetic formulations containing same |
| 07/16/2002 | CA2367186A1 Method for preventing and treating skin aging |
| 07/16/2002 | CA2230097C Stable oil-in-water-emulsion, the procedure involved in its manufacture and its use in cosmetic and dermatological products |
| 07/16/2002 | CA2197702C Use of a 2-amino-alkane-1,3-diol to slow loss of hair and/or stimulate or induce hair growth |
| 07/16/2002 | CA2165521C Topical composition containing a p substance antagonist |
| 07/16/2002 | CA2165519C P substance antagonist used for the treatment of itching, ocular and/or palpebral algia and ocular and/or palpebral dysesthesia |
| 07/16/2002 | CA2165518C P substance antagonist used for the treatment of neurogenous skin redness |
| 07/16/2002 | CA2131383C Wound healing and treatment of fibrotic disorders |
| 07/16/2002 | CA2104452C Treatment of cellulite with retinoids |
| 07/16/2002 | CA2050875C 3-(1h-indazol-3-yl)-4-pyridinamines, a process and intermediates for their preparation and their use as medicaments |
| 07/11/2002 | WO2002053773A2 Method for determining skin stress or skin ageing in vitro |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053565A1 Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient |
| 07/11/2002 | WO2002053534A1 Vla-4 inhibitors |
| 07/11/2002 | WO2002053523A1 Tropolone derivative |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053172A2 Use of matrix metalloproteinase peptide substrate to lower the rate of extracellular matrix turnover |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053170A2 Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with fo |
| 07/11/2002 | WO2002053150A1 Preventives for wound adhesion |
| 07/11/2002 | WO2002053141A2 Inhibition of angiogenesis by nucleic acids |
| 07/11/2002 | WO2002053127A1 Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002053089A2 Stable skin conditioning compositions containing retinoid boosters |
| 07/11/2002 | WO2002028480A3 Methods of therapy for b-cell malignancies |
| 07/11/2002 | WO2002017914A8 Fused pyrrolocarbazoles against inflammation |
| 07/11/2002 | WO2002010199A3 C3b/c4b complement receptor-like molecules and uses thereof |
| 07/11/2002 | WO2002008221A3 Capsaicin receptor ligands |
| 07/11/2002 | WO2001095890B1 Oral pharmaceutical compositions containing terbinafine |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001041715A3 Ultraviolet radiation absorbing waxes useful in cosmetic compositions |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | WO2001010430A9 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 07/11/2002 | US20020091270 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 07/11/2002 | US20020091266 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/11/2002 | US20020091251 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 07/11/2002 | US20020091240 Humanized antibodies to gamma-interferon |
| 07/11/2002 | US20020091143 Use of 4-substituted tetrahydropyridines for the manufacture of medicament s acting upon TGF-beta 1 |
| 07/11/2002 | US20020091128 Combination of gaba agonists and sorbitol dehydrogenase inhibitors |
| 07/11/2002 | US20020091127 Semicarbazides and their uses |
| 07/11/2002 | US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
| 07/11/2002 | US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| 07/11/2002 | US20020091105 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 07/11/2002 | US20020090703 Mammalian protein phosphatases |
| 07/11/2002 | US20020090624 Gene markers useful for detecting skin damage in response to ultraviolet radiation |
| 07/11/2002 | US20020090401 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia |
| 07/11/2002 | US20020090384 Anti-irritant compositions containing a cyclic nucleotide |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2433559A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221443A1 Substituted imidazolidinone derivatives |
| 07/10/2002 | EP1221441A2 LTA4 Hydrolase inhibitors |
| 07/10/2002 | EP1221325A2 A wound healing antiscarring topical composition of centella and ginseng |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |